Drug regimen review · Pharmacy Service Deficiencies
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
F756 in Indiana. Pick another state for the same tag.
Against expectation — 2025
Indiana cites F756 less often than its own record predicts
Versus expected share0.96×
0.96 times the national share — cited less often here than elsewhere.
Share of Indiana citations0.76%
Of every deficiency written in Indiana in 2025, this is the portion that was F756.
Indiana0.76%
National0.79%
Share of all citations that were F756.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Indiana surveyors wrote
F756 findings written in Indiana, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedMay 21, 2026
Based on record review and interview the facility failed to ensure pharmacy recommendations were appropriately reviewed and addressed timely by a medical professional for 2 of 5 Residents (Resident 11 and 81) reviewed for unnecessary medications.Findings include:A pharmacy recommendation dated 10/28/25 indicated Resident 11 had an order for Aspirindaily, Carbidopa/Levodopa (a medication used to treat Parkinson's disease.) extended release three times a day and Nitrofurantoin (an oral antibiotic used primarily to treat and prevent uncomplicated bacterial urinary tract infections). …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction